Vanuatu Technology Update: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Vanuatu Technology Update.

Press releases published on September 30, 2026

36 minutes ago

Cycurion Discusses Record Contract Win, Public Safety Expansion and Growth Strategy in New Interview

Indeterminate GlobeNewswire

an hour ago

AGM Group Advances AI Inference Strategy, Storage Integration and Server Deliveries

Indeterminate GlobeNewswire

an hour ago

Wave Life Sciences Announces GSK’s Selection of siRNA program to Transition to GSK for Further Development

Indeterminate GlobeNewswire

an hour ago

Cerenome Expects $1.55 Million in CNSide® Third Quarter Gross Billings

Indeterminate GlobeNewswire

an hour ago

Arbutus Announces Preliminary Results of Its US$230 Million Modified “Dutch Auction” Tender Offer

Indeterminate GlobeNewswire

2 hours ago

Ocugen to Participate in Upcoming Scientific Conferences

Indeterminate GlobeNewswire

2 hours ago

R1 Therapeutics expands Series A to $80.5 million to advance global Phase 2b program in hyperphosphatemia

Indeterminate GlobeNewswire

2 hours ago

EVerZom successfully completes CTA-enabling preclinical studies of EVerGel™ required to support a clinical trial application

Indeterminate GlobeNewswire

2 hours ago

More Than 1,600 Participants Anchor Calroy Health Sciences' Joint Formulation Research

Indeterminate GlobeNewswire

2 hours ago

FactSet Reports Results for Fourth Quarter and Fiscal 2026

Indeterminate GlobeNewswire

2 hours ago

Adlai Nortye Appoints Christopher Liu, PharmD, as Head of Investor Relations and Public Relations

Indeterminate GlobeNewswire

2 hours ago

Pharmazz, Inc. Receives U.S. FDA IND Clearance to Initiate Phase 3 Clinical Trial of Sovateltide in Traumatic Brain Injury

Indeterminate GlobeNewswire

2 hours ago

Rafael Holdings Announces Topline Results from the Pivotal Phase 3 TransportNPC™ Study of Trappsol® Cyclo™ in Niemann-Pick Disease Type C (NPC)

Indeterminate GlobeNewswire

2 hours ago

Satellos Announces Completion of Enrollment in BASECAMP Phase 2 Clinical Trial of Forazapadin for Duchenne Muscular Dystrophy

Indeterminate GlobeNewswire

2 hours ago

10 Barrel Expands Salty Sips RTD Portfolio with New Blackberry Refresher

Indeterminate GlobeNewswire

2 hours ago

Connect Biopharma Announces Positive Preliminary Topline Data from its Global Phase 2 Study of Rademikibart as an Add-on Treatment for Acute Exacerbations in Adults with COPD and Type 2 Inflammation

Indeterminate GlobeNewswire

2 hours ago

Kailera Therapeutics Announces Completion of Enrollment in KaiNETIC Global Phase 3 Clinical Program of GLP-1/GIP Receptor Dual Agonist Ribupatide Injection

Indeterminate GlobeNewswire

2 hours ago

Jade Biosciences Announces Preclinical Data Characterizing JADE301, a Potentially Best-in-Class, Half-Life-Extended Anti-IFN-β Monoclonal Antibody in Development for Dermatomyositis, at EADV 2026

Indeterminate GlobeNewswire

2 hours ago

Harrow Ophthalmic Portfolio Highlighted in 15 Scientific Presentations at AAOpt and AAO

Indeterminate GlobeNewswire

2 hours ago

ONAR Completes Largest Acquisition in Company History: Advertise Purple Adds $17.1 Million of Revenue and $4.4 Million of Net Income, Bringing Combined Pro Forma Revenue to Approximately $23.5 Million

Indeterminate GlobeNewswire